PFIZER Tag

17 February 2022 Embargo: Immediate release Until recently, the treatment options for patients with mild-to-moderate COVID-19 have been limited. New oral antiviral medicines are becoming available for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen and who are at risk of...

Embargo: Immediate release SAHPRA registered two COVID-19 vaccines: the COMIRNATY vaccine by Pfizer Laboratories (Pty) Ltd on 25 January 2022, and the COVID-19 VACCINE MC PHARMA by MC Pharma (Pty) Ltd. on 31 January 2022. Both vaccines have been registered in terms of section 15 of...

26 July 2021 The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal of myocarditis/pericarditis associated with Pfizer-BioNTech’s Covid-19 vaccine, Comirnaty® (BNT162b2). The Pfizer/BioNTech Comirnaty® Vaccine was approved by SAHPRA in March 2021. The authorisation was done in terms of...

13 July 2021 Healthcare professionals and public health authorities have a central role in discussing vaccination against COVID-19 with their patients. Vaccines play a critical role in preventing deaths, hospitalisation caused by infectious diseases. Emerging data on effectiveness indicates that licenced COVID-19vaccines are contributing to controlling...